Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan in Pulmonary Arterial Hypertension
NCT06053580Phase 2Recruiting
- Sponsor
- University of Washington
- Start
- Feb 2024
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valsartan in pulmonary arterial hypertension (PAH), sponsored by University of Washington. Started Feb 2024; status: recruiting.
02
Drugs
valsartan
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT06053580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06053580.